Physician profile
Robert S Schubert
NPI 1972537884
$1,847.58
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $627 · 2020: $198 · 2021: $174 · 2022: $149 · 2023: $250 · 2024: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $550.23 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $454.75 | 2019-2023 | Cyltezo |
| Astrazeneca Pharmaceuticals LP | $186.36 | 2019-2024 | Farxiga |
| Exact Sciences Corporation | $101.72 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $101.44 | 2023-2024 | |
| Novo Nordisk INC | $84.39 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Sanofi-Aventis U.S. LLC | $73.35 | 2020-2022 | |
| Abbvie INC. | $63.62 | 2023-2024 | Qulipta, Ubrelvy |
| E.R. Squibb & Sons, L.L.C. | $48.49 | 2023-2024 | Eliquis |
| Phathom Pharmaceuticals, INC. | $45.00 | 2024 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $25.80 | 2022 | |
| Shire North American Group INC | $22.16 | 2019 | |
| Dynavax Technologies Corporation | $20.92 | 2023 | Heplisav-B |
| Alk-Abello, INC | $17.59 | 2024 | Grastek, Ragwitek, Odactra |
| Electromed, INC. | $15.80 | 2024 | Smartvest |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.18 | 2022 | |
| Tandem Diabetes Care, INC. | $11.51 | 2021 | |
| Insulet Corporation | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Schubert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.